Glycogen storage disease type 1a in three siblings with the G270V mutation

¹Genetic Institute, Soroka Medical Center, Beer Sheva, Israel. ruthi@bgumail.bgu.ac.il

|May 11, 1999

Summary

Glycogen storage disease type 1a (GSD1a) is a genetic disorder caused by a deficiency in glucose-6-phosphatase activity. A specific mutation (G270V) in a GSD1a family resulted in milder symptoms than typically observed.

Area of Science:

Biochemistry
Genetics
Pediatrics

Background:

Glycogen storage disease type 1a (GSD1a), also known as von Gierke disease, results from deficient microsomal glucose-6-phosphatase (G6Pase) activity.
Understanding the genetic basis of GSD1a has been advanced by cloning G6Pase cDNA and characterizing the human G6Pase gene, facilitating mutation identification.

Observation:

This study examined three siblings from a Muslin Arab family diagnosed with GSD1a.
The patients carried a specific G270V mutation in the G6Pase gene.

Findings:

Two older siblings exhibited a notably milder clinical presentation and biochemical profile than typically associated with GSD1a.
The identified G270V mutation may correlate with a less severe phenotype in GSD1a patients.

Implications:

These findings contribute to the understanding of genotype-phenotype correlations in GSD1a.
Further research into the G270V mutation could inform personalized treatment strategies for glycogen storage disease type 1a.

Related Experiment Videos

Glycogen storage disease type 1a in three siblings with the G270V mutation

Related Concept Videos

MHC class 2 deficiency and X-linked agammaglobulinaemia in a consanguineous extended family.

The PREPL A protein, a new member of the prolyl oligopeptidase family, lacking catalytic activity.

A novel lymphocyte signaling defect: trk A mutation in the syndrome of congenital insensitivity to pain and anhidrosis (CIPA).

Carnitine-acylcarnitine translocase deficiency: identification of a novel molecular defect in a Bedouin patient.

Congenital insensitivity to pain. Orthopaedic manifestations.

Neurophysiologic studies in congenital insensitivity to pain with anhidrosis.

From Common Pathway to Divergent Diseases: Metabolic Aspects of Inborn Errors of CoA Biosynthesis.

Proteo-Metabolomic Profiling of PMM2-CDG Reveals Dysregulation of Retinoic Acid Synthesis, Myo-Inositol, and the Hexosamine Pathway.

High-Protein Diet Ameliorates Cardiomyopathy in a Cardiac-Specific AGL Knockout Mouse Model: Association With Upregulated Hepatic Gluconeogenesis.

Behavioral Phenotyping of the Pahenu2 Mouse Model for Phenylketonuria-A Scoping Review and Future Perspectives.

Baat-Deficient Mice Recapitulate Elevated 7α-Hydroxy-3-Oxo-4-Cholestenoic Acid Observed in a Japanese Patient With BAAT Deficiency.

Creatine Supplementation Reduces Guanidinoacetate via Downregulation of AGAT in a Mouse Model of GAMT Deficiency.

Whole-genome resequencing with multidimensional annotation revealed pathogenic networks in sirenomelia.

Human Loss-of-Function ZNRF3 Mutation Impairs Adipose Thermogenesis and Drives Subcutaneous Fat Expansion.

Integrated genetic identification and molecular dynamics simulations in a novel LOXL3 genetic mutation associated with Stickler syndrome.

The ZBTB16/CUL3/ROC1 ubiquitin ligase drives the degradation of pathogenic pendrin (SLC26A4) protein variants.

Identification and functional characterization of a SUZ12 frameshift variant in a Chinese family with Imagawa-Matsumoto syndrome.

The first 25 years of the NICHD Structural Birth Defects Initiative.

Related Experiment Videos

Glycogen storage disease type 1a in three siblings with the G270V mutation

Area of Science:

Background:

Observation:

Findings:

Implications:

Related Concept Videos

Related Articles